Benign tumors can usually be resected using microsurgical techniques and new technology adjuncts such as ultrasonic aspirators and lasers. The prognosis in malignant tumors remains unsatisfactory, but new advances with chemotherapy, immunotherapy, and possibly radiosensitizers are encouraging. To fully develop such advances will require continued laboratory investigation and patient referrals to centers carrying on new clinical trials.
|Original language||English (US)|
|Number of pages||9|
|State||Published - Jan 1 1983|
ASJC Scopus subject areas